Invention Grant
- Patent Title: Method for treating cancer using chemokine antagonists
-
Application No.: US16551525Application Date: 2019-08-26
-
Publication No.: US10993953B2Publication Date: 2021-05-04
- Inventor: John A. Zebala , Dean Y. Maeda , Aaron D. Schuler
- Applicant: SYNTRIX BIOSYSTEMS INC.
- Applicant Address: US WA Auburn
- Assignee: SYNTRIX BIOSYSTEMS INC.
- Current Assignee: SYNTRIX BIOSYSTEMS INC.
- Current Assignee Address: US WA Auburn
- Agency: Knudsen Law LLC
- Main IPC: A61K31/69
- IPC: A61K31/69 ; A61K9/00 ; A61K45/06 ; A61K31/495 ; C07K16/28 ; A61K39/395 ; G01N33/574 ; A61K9/10 ; A61K47/38 ; A61K9/16 ; A61K31/555 ; A61P35/00 ; C12Q1/6886 ; A61K39/00 ; A61K31/282 ; A61K35/12
Abstract:
What is described is a method for treating cancer in a patient assaying levels of (a) CXCR1 and/or CXCR2 ligands or (b) myeloid derived suppressor cells (MDSCs) and/or neutrophils in the patient, and if the patient has increased levels of (a) or (b), then administering a therapeutically effective amount of a compound having a structure selected from the group consisting of formulas SX-517, SX-576, and SX-682
Public/Granted literature
- US20190381076A1 METHOD FOR TREATING CANCER USING CHEMOKINE ANTAGONISTS Public/Granted day:2019-12-19
Information query
